Quantcast

Latest early-stage breast cancer Stories

2013-04-18 23:19:36

Cianna Medical, Inc: Recent studies conclude breast brachytherapy with the SAVI applicator appears to be a well-tolerated, effective treatment for early-stage breast cancer. New Orleans, Louisiana (PRWEB) April 18, 2013 Breast brachytherapy with a strut-based applicator demonstrated low recurrence rates and minimal toxicities, according to a multi-site study with a median follow-up of four years. The research was presented at the annual meeting of the American Brachytherapy Society, held in...

2013-01-28 15:50:53

Patients with early stage breast cancer who were treated with lumpectomy plus radiation may have a better chance of survival compared with those who underwent mastectomy, according to Duke Medicine research. The study, which appears online Jan. 28, 2013, in the journal Cancer, raises new questions as to the comparative effectiveness of breast-conserving therapies such as lumpectomy, where only the tumor and surrounding tissue is surgically removed. “Our findings are observational...

2012-01-10 23:33:23

Journal of the American College of Surgeons Study Reveals Need for Improvements in Decision-Making Process for Breast Cancer Surgery Patients According to the results of a new study published in the January 2012 issue of the Journal of the American College of Surgeons, many early-stage breast cancer survivors lacked knowledge about their disease and were not meaningfully involved in treatment discussions or asked their preferences regarding the approach to treatment. As a result, the...

2011-10-06 09:54:37

Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday. The study also found that a regimen without the drug Adriamycin, an anthracycline commonly used as a mainstay to treat breast cancer but one that, especially when paired...

2011-09-07 14:13:23

University of Maryland study analyzed data from nearly 15,000 patients Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco....

2011-07-26 22:03:11

Study reported in Journal of the American Medical Association A new study shows that removing lymph nodes due to the presence of occult, or microscopic, cancer cells found in the sentinel lymph node "“ the one closest to the tumor -- has no impact on survival outcomes of women with early-stage breast cancer. The principal investigator of the study is Armando E. Giuliano, MD, of Cedars-Sinai, who already is renowned for his clinical expertise and for his seminal research on lymph node...

2011-05-18 17:00:00

REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from ten separate studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7, 2011 at McCormick Place in Chicago. The company markets the widely-adopted Oncotype DX® breast cancer test, which is clinically validated to predict chemotherapy benefit as well as the likelihood of recurrence in...

2011-03-17 08:30:00

REDWOOD CITY, Calif. and ST. GALLEN, Switzerland, March 17, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from nine studies utilizing the Oncotype DX® test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland. The studies included region-specific decision impact data that demonstrated the knowledge of a patient's Recurrence Score® (RS)...

2010-12-13 07:00:00

SAN ANTONIO, Dec. 13, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from seven new studies focusing on its multigene Oncotype DX(®) breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide. The data, presented this past week at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), further confirm the clinical value associated with the Oncotype DX Recurrence...

2010-12-10 07:46:44

(Ivanhoe Newswire) -- Postmenopausal women fighting a specific form of breast cancer may get some help through innovative use of two enzyme-inhibiting drugs. In hormone-receptor positive, early-stage breast cancer, estrogen causes tumor growth and must be treated with surgery.  Following surgery, patients of this form of breast cancer are therefore administered drugs which seize the production of estrogen for five years.  The drugs work by inhibiting the aromatase enzyme, which...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'